Biotech

All Articles

Former Seagen chief executive officer reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer in 2015 for a whoppin...

Ironwood creates more bid for $1B GI medication with brand-new subgroup records

.On the heels of a period 3 win that neglected to excite financiers, Ironwood Pharmaceuticals is bac...

Novartis inks $150M package for autoimmune molecular adhesive

.Do not quit Monte Rosa Therapeutics currently. The Boston-based biotech is enjoying after signing a...

Jade takes exec group with Chinook vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings and ...

Septerna goes public along with upsized offering of $288M

.Commemorating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fi...

AbbVie brings in Richter richer, paying for $25M to form discovery contract

.AbbVie has actually gone back to the source of its antipsychotic powerhouse Vraylar seeking one mor...

GenSight goes into final full weeks of cash money path as revenue flow edges out of reach

.GenSight Biologics is full weeks off of losing funds. Once again. The biotech only has sufficient c...

AZ licenses thrown away uncommon ailment drug to Monopar Therapies

.Monopar Rehabs is actually recovering a medication coming from the scrap heap of AstraZeneca's unco...

Arcus' new HIF-2a data in kidney cancer cells mean prospective edge over Merck's Welireg, experts say

.With brand new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ex...

Roche bets around $1B to expand Dyno gene therapy shipment pact

.After creating a genetics treatment partnership with Dyno Rehabs in 2020, Roche is back for more.In...